Joel A. Lefferts, PhD
Associate Professor of Pathology and Laboratory Medicine
Assistant Director, Clinical Genomics and Advanced Technology Laboratory
Pathology and Laboratory Medicine
PhD, Rutgers Graduate School of Biomedical Sciences (University of Medicine & Dentistry of New Jersey), Newark, NJ , 2006
Molecular Pathology Fellowship, Dartmouth-Hitchcock Medical Center, Geisel School of Medicine at Dartmouth, Lebanon, NH 2006-2010
Department of Pathology
One Medical Center Drive
Lebanon NH 03756
Implementation of Reverse Transcriptase Polymerase Chain Reaction Testing for Severe Acute Respiratory Syndrome Coronavirus-2 Under the U.S. Food and Drug Administration Emergency Use Authorization.
Novel LRRFIP2-RAF1 fusion identified in an acral melanoma: A review of the literature on melanocytic proliferations with RAF1 fusions and the potential therapeutic implications.
Concordance Analysis of the 23-Gene Expression Signature (myPath Melanoma) With Fluorescence In Situ Hybridization Assay and Single Nucleotide Polymorphism Array in the Analysis of Challenging Melanocytic Lesions: Results From an Academic Medical Center.
Molecular genetic profiling reveals novel association between FLT3 mutation and survival in glioma.
Implementation of an Emergency Use Authorization Test During an Impending National Crisis.
Lessons Learned from Direct-to-Consumer Genetic Testing.
CD10 and p63 expression in a sarcomatoid undifferentiated melanoma: A cautionary (and molecularly annotated) tale.
A case of molecularly confirmed BAP1 inactivated melanocytic tumor with retention of immunohistochemical expression: A confounding factor.
Molecular Characterization of a Rare Dedifferentiated Liposarcoma With Rhabdomyosarcomatous Differentiation in a 24 Year Old.
BAP1-deficient tumor/nevus with germline aberration: A potential pitfall in assessing melanocytic neoplasms with single nucleotide polymorphism array.